Pharmacogenetic markers and macrolide safety in influenza patients: insights from a prospective study
Genetic polymorphisms in <i>ABCB1</i> and <i>CYP3A4</i> genes predict macrolide-related ADRs. Pharmacogenetic screening could improve macrolide safety, particularly for genetically susceptible individuals.
Authors
- В. В. Никифоров (ORCID: https://orcid.org/0000-0002-2205-9674)
- Anna Aleksandrovna Skryabina (ORCID: https://orcid.org/0000-0002-2098-222X)
- Murad Z. Shakhmardanov (ORCID: https://orcid.org/0000-0002-3168-2169)
- Dmitry Alekseevich Sychev (ORCID: https://orcid.org/0000-0002-4496-3680)
- Михаил Сергеевич Застрожин (ORCID: https://orcid.org/0000-0002-3964-9726)
Institutions
- University of California, San Francisco (US)
- University of California System (US)
- Pirogov Russian National Research Medical University (RU)
- Russian Medical Academy of Continuous Professional Education (RU)
Publication Details
- Journal
- Pharmacogenomics
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1080/14622416.2025.2454217
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00